Tag: antibody treatments

Vanderbilt Joins National Effort to Speed Ebola Therapy Testing

Vanderbilt University researchers have joined a multi-center effort led by Pennsylvania-based Inovio Pharmaceuticals Inc. to accelerate development of potential antibody therapies against the often-lethal Ebola virus. On Wednesday, Inovio announced it had been awarded an initial two-year, $21-million grant from the Defense Advanced Research Projects Agency (DARPA), part of the U.S. Department of Defense, to support the project. Vanderbilt’s share...

Continue reading